Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C12H12N2O2 |
| Molecular Weight | 216.2359 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C1N=C(NC2CC2)OC1C3=CC=CC=C3
InChI
InChIKey=DNRKTAYPGADPGW-UHFFFAOYSA-N
InChI=1S/C12H12N2O2/c15-11-10(8-4-2-1-3-5-8)16-12(14-11)13-9-6-7-9/h1-5,9-10H,6-7H2,(H,13,14,15)
| Molecular Formula | C12H12N2O2 |
| Molecular Weight | 216.2359 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Cyclazodone is a stimulant drug developed by American Cyanamid Company. Administration of the drug led to an increase in spontaneous activity. The compound is claimed to be useful as a psychotonic drug in depressive states, anxiety, as an anti-fatigue agent, and as an anorexigenic drug. The compound is included in the World Anti-Doping Agency prohibited list.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 17:05:25 GMT 2023
by
admin
on
Sat Dec 16 17:05:25 GMT 2023
|
| Record UNII |
O8U55ZRL9K
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C47795
Created by
admin on Sat Dec 16 17:05:26 GMT 2023 , Edited by admin on Sat Dec 16 17:05:26 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
135438121
Created by
admin on Sat Dec 16 17:05:26 GMT 2023 , Edited by admin on Sat Dec 16 17:05:26 GMT 2023
|
PRIMARY | |||
|
O8U55ZRL9K
Created by
admin on Sat Dec 16 17:05:26 GMT 2023 , Edited by admin on Sat Dec 16 17:05:26 GMT 2023
|
PRIMARY | |||
|
C81049
Created by
admin on Sat Dec 16 17:05:26 GMT 2023 , Edited by admin on Sat Dec 16 17:05:26 GMT 2023
|
PRIMARY | |||
|
CHEMBL2106536
Created by
admin on Sat Dec 16 17:05:26 GMT 2023 , Edited by admin on Sat Dec 16 17:05:26 GMT 2023
|
PRIMARY | |||
|
14461-91-7
Created by
admin on Sat Dec 16 17:05:26 GMT 2023 , Edited by admin on Sat Dec 16 17:05:26 GMT 2023
|
PRIMARY | |||
|
CYCLAZODONE
Created by
admin on Sat Dec 16 17:05:26 GMT 2023 , Edited by admin on Sat Dec 16 17:05:26 GMT 2023
|
PRIMARY | |||
|
SUB06844MIG
Created by
admin on Sat Dec 16 17:05:26 GMT 2023 , Edited by admin on Sat Dec 16 17:05:26 GMT 2023
|
PRIMARY | |||
|
100000083747
Created by
admin on Sat Dec 16 17:05:26 GMT 2023 , Edited by admin on Sat Dec 16 17:05:26 GMT 2023
|
PRIMARY | |||
|
2173
Created by
admin on Sat Dec 16 17:05:26 GMT 2023 , Edited by admin on Sat Dec 16 17:05:26 GMT 2023
|
PRIMARY | |||
|
DTXSID60864509
Created by
admin on Sat Dec 16 17:05:26 GMT 2023 , Edited by admin on Sat Dec 16 17:05:26 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
